Search

Displaying results 4091 - 4100 of 4188 in total
  1. Drug

    Ofatumumab

    go.drugbank.com/drugs/DB06650
    ApprovedInvestigational

    [L15581] The potential therapeutic use of ofatumumab in various lymphomas and rheumatoid arthritis has also been investigated.[A193053]

  2. Drug

    Sinapultide

    go.drugbank.com/drugs/DB11332
    ApprovedWithdrawn

    Surfactant replacement therapy has been commonly used to prevent and treat RDS in these newborns and is now a standard of care.

  3. Drug

    Urea C-13

    go.drugbank.com/drugs/DB09510
    ApprovedInvestigational

    H pylori is a common stomach bacteria that has been linked to a variety of upper gastrointestinal disorders such as gastritis, gastric and peptic ulcers, stomach cancer, and gastric mucosa-associated lymphoid-tissue

  4. Drug

    Urea C-14

    go.drugbank.com/drugs/DB09513
    ApprovedInvestigational

    H pylori is a common stomach bacteria that has been linked to a variety of upper gastrointestinal disorders such as gastritis, gastric and peptic ulcers, stomach cancer, and gastric mucosa-associated lymphoid-tissue

  5. Drug

    Cocoa butter

    go.drugbank.com/drugs/DB11086
    Approved

    The lipid-lowering effects of cocoa butter have been studied and investigated, as fatty acid constituents of cocoa butter are known to exhibit lipid-lowering properties.

  6. Drug

    H3B-8800

    go.drugbank.com/drugs/DB14017
    Investigational

    H3B-8800 is a novel spliceosome inhibitor developed by H3 Biomedicine . It offers the benefit of preferentially killing spliceosome-mutant cancer cells whereas other splicesome inhibitors, such as the pladienolide analogue E7107, show no...

  7. Drug

    Ivarmacitinib

    go.drugbank.com/drugs/DB16756
    Investigational

    Ivarmacitinib (SHR0302) is a selective inhibitor of Janus kinase 1 (JAK1) under investigation for the treatment of various immuno-inflammatory conditions. While ivarmactinib has yet to receive marketing authorization, as of February 2022...

  8. Drug

    Siagoside

    go.drugbank.com/drugs/DB12351
    Investigational

    Siagoside (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease.

  9. Drug

    Human interferon omega-1

    go.drugbank.com/drugs/DB05472
    Investigational

    It has been investigated both in single and combination treatment. The biological activities of IFN-omega 1 and its physiological role are not known to date.

  10. Drug

    Tanaproget

    go.drugbank.com/drugs/DB04787
    Experimental

    An analog of tanaproget, 4-fluoropropyltanaproget (18F), has been developed as a radiotracer for imaging of the PR in positron emission tomography.